CytRx (CYTR) Income Statement

Click line-items for a historical chart and %

Revenue:
License revenue	0
Expenses:
Research and development	8.93M
General and administrative	2.77M
Total expenses
Loss before other income	-11.7M
Other income:
Interest income
Other income, net
Gain on warrant derivative liability	246.21K
Gain on sale of affiliate's shares - RXi Pharmaceutical
Loss before provision for income taxes
Provision for income taxes
Net income (loss)	-12.18M
Other comprehensive income (net of tax)
Unrealized gain on available-for-sale securities
Comprehensive income (loss)
Basic net income (loss) per share (in dollars per share)
Basic weighted average shares outstanding (in shares)
Diluted net income (loss) per share (in dollars per share)
Diluted weighted average shares outstanding (in shares)

Entities mentioned with CYTR